Anzeige
Mehr »
Login
Dienstag, 24.05.2022 Börsentäglich über 12.000 News von 667 internationalen Medien
Gamechanger-Meldung am späten Montagabend! Dienstagmorgen gleich ins Depot?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14XCV ISIN: US98986X1090 Ticker-Symbol: 6ZY 
Frankfurt
23.05.22
08:10 Uhr
0,893 Euro
-0,065
-6,78 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
ZYNERBA PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
ZYNERBA PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,9400,95823.05.
0,8810,96423.05.

Aktuelle News zur ZYNERBA PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
ZYNERBA PHARMACEUTICALS Aktie jetzt für 0€ handeln
16.05.Zynerba Pharmaceuticals R&D Expenses Reach $5.1M For Q1 2022, Here Are The Details2
16.05.Zynerba Pharmaceuticals, Inc. - 10-Q, Quaterly Report1
16.05.Zynerba Pharmaceuticals, Inc. - 8-K, Current Report-
16.05.Zynerba Pharmaceuticals, Inc.: Zynerba Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights3
11.05.Zynerba Pharmaceuticals, Inc.: Zynerba Pharmaceuticals Presents Long-Term Safety and Efficacy Data of Zygel in Children and Adolescents with Fragile X ...3
09.05.Zynerba Pharmaceuticals, Inc.: Zynerba Pharmaceuticals Announces Podium Presentation at the International Society for Autism Research Annual Meeting2
02.05.Zynerba Pharmaceuticals, Inc.: Zynerba Pharmaceuticals Presents Long-Term Safety and Efficacy Data of Zygel in Children and Adolescents with Fragile X ...2
21.04.Zynerba Pharmaceuticals, Inc.: Zynerba Pharmaceuticals Announces Presentation of Poster at the 2022 Society of Biological Psychiatry Annual Meeting2
05.04.Zynerba Pharmaceuticals, Inc.: Zynerba Pharmaceuticals to Present at the Needham Virtual Healthcare Conference3
22.03.Zynerba Pharmaceuticals, Inc.: Zynerba Pharmaceuticals to Participate in the Cantor Rare Orphan Disease Summit2
01.03.Zynerba Pharmaceuticals Reveals Lower Net Loss For Q4 And Full Year 20211
01.03.Zynerba Pharmaceuticals, Inc. - S-8, Securities to be offered to employees in employee benefit plans-
01.03.Zynerba Pharmaceuticals, Inc. - 8-K, Current Report-
01.03.Zynerba Pharmaceuticals, Inc. - 10-K, Annual Report-
01.03.Zynerba Pharmaceuticals GAAP EPS of -$0.22 beats by $0.04-
01.03.Zynerba Pharmaceuticals, Inc.: Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights2
28.02.Zynerba Pharma gets orphan drug designation from European Commission for Zygel in FXS3
28.02.Zynerba Pharmaceuticals, Inc.: Zynerba Pharmaceuticals Announces European Commission Has Granted Orphan Drug Designation for Zygel in Fragile X Syndrome1
17.02.Cannabis Movers & Shakers: Cresco, Agricor & Botanacor, C3 Industries, Akanda, CULTA, OWP, Zynerba5
15.02.Zynerba Pharmaceuticals Names New CLO & Corporate Secretary-
Seite:  Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1